Z79.818
Billable codeLong term (current) use of other agents affecting estrogen receptors and estrogen levels
The ICD-10 code for long term (current) use of other agents affecting estrogen receptors and estrogen levels is Z79.818.
Clinical notes
Also known as
Alternate wording, synonyms, or specific conditions that fall under this code, listed to help confirm you've picked the right one.
- Long term (current) use of estrogen receptor downregulators
- Long term (current) use of fulvestrant (Faslodex)
- Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
- Long term (current) use of goserelin acetate (Zoladex)
- Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
- Long term (current) use of megestrol acetate (Megace)
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- Z79.810Long term (current) use of selective estrogen receptor modulators (SERMs)
- Z79.811Long term (current) use of aromatase inhibitors
- Z79.818Long term (current) use of other agents affecting estrogen receptors and estrogen levels
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- V0759
Associated MS-DRGs
Z79.818 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.